| RS2497417047 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2497417818 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2497419319 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2497419394 |
OTOG
|
Health Risk |
Likely pathogenic |
— |
| RS2497421036 |
VWF
|
Health Risk |
Likely pathogenic |
— |
| RS2497421495 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2497421894 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497421927 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS2497423187 |
STIM1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to STIM1 deficiency, Myopathy with tubular aggregates |
| RS2497425796 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497426310 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497427091 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS2497432294 |
OTOG
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS2497432698 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497434558 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2497436869 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS2497437523 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497439641 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497440458 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2497444053 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2497444581 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2497445719 |
ETV6
|
Health Risk |
Likely pathogenic |
Malignant lymphoma, large B-cell |
| RS2497448284 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2497449184 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2497451715 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497452054 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497452998 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2497453440 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2497453463 |
VWF
|
Health Risk |
Likely pathogenic |
— |
| RS2497455398 |
HEPACAM
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2A |
| RS2497460931 |
VWF
|
Health Risk |
Pathogenic |
— |
| RS2497463030 |
HEPACAM
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2A |
| RS2497465356 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497466492 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497466564 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497466869 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497467469 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497468901 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497470215 |
HEPACAM
|
Health Risk |
Pathogenic |
— |
| RS2497470975 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497471018 |
GRIN2B
|
Health Risk |
Likely pathogenic |
GRIN2B-related disorder, GRIN2B-related disorder |
| RS2497471386 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2497471442 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497471746 |
GRIN2B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2497471781 |
GRIN2B
|
Health Risk |
Likely pathogenic |
— |
| RS2497472277 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2497475225 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497475280 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497475506 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497475732 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2497475889 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497476034 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2497476072 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2497476150 |
ALG9
|
Health Risk |
Likely pathogenic |
ALG9-related disorder, ALG9-associated autosomal dominant polycystic kidney disease |
| RS2497479294 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2497481899 |
GRIN2B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2497482245 |
GRIN2B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2497482289 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2497482397 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2497485773 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497486003 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2497489266 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2497489299 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2497501143 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 13, DPAGT1-congenital disorder of glycosylation |
| RS2497504527 |
OTOG
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2497505797 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2497512202 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497512303 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497512441 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS2497512444 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS2497515136 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2497516107 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS2497516912 |
VWF
|
Health Risk |
Likely pathogenic |
VWF-related disorder, VWF-related disorder |
| RS2497517912 |
FLI1
|
Health Risk |
Pathogenic |
Bleeding disorder, platelet-type |
| RS2497522036 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS2497522154 |
FERRY3
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 66 |
| RS2497522170 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497522237 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497522528 |
MED17
|
Health Risk |
Likely pathogenic |
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly, Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly |
| RS2497527392 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS2497527420 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497527611 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS2497527773 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497528475 |
DPAGT1
|
Health Risk |
Likely pathogenic |
DPAGT1-congenital disorder of glycosylation, DPAGT1-congenital disorder of glycosylation |
| RS2497529042 |
VWF
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2497529439 |
DPAGT1
|
Health Risk |
Pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS2497530420 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497531947 |
OTOG
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2497533462 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS2497535795 |
VWF
|
Health Risk |
Likely pathogenic |
Hereditary von Willebrand disease, Hereditary von Willebrand disease |
| RS2497536470 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS2497538745 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS2497538753 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2497539228 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2497544328 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2497544750 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2497545192 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2497546422 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS2497547053 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2497551789 |
MED17
|
Health Risk |
Pathogenic |
— |